South Korea Pharmacy Market

South Korea Pharmacy Market Research Report: Size, Share, Trend Analysis By Product Type (Prescription Drugs, Over-The-Counter Drugs, Vaccines, Homeopathic Medicine), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy, Specialty Pharmacy), By Therapeutic Area (Cardiovascular, Oncology, Diabetes, Neurology, Infectious Diseases) and By Formulation (Tablets, Injectables, Topicals, Liquids) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period
2025 - 2035
CAGR
4.1%
2024 Market Size
$ 22.5 Billion
2035 Market Size
$ 35 Billion
Medical Device ● Updated February 2026 Report ID: MRFR/MED/50762-HCR | Pages: 200 | Author: Nidhi Mandole, Garvit Vyas
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Product Type (USD Billion)
      1. 4.1.1 Prescription Drugs
      2. 4.1.2 Over-The-Counter Drugs
      3. 4.1.3 Vaccines
      4. 4.1.4 Homeopathic Medicine
    2. 4.2 Pharmaceutical, BY Distribution Channel (USD Billion)
      1. 4.2.1 Retail Pharmacy
      2. 4.2.2 Hospital Pharmacy
      3. 4.2.3 Online Pharmacy
      4. 4.2.4 Specialty Pharmacy
    3. 4.3 Pharmaceutical, BY Therapeutic Area (USD Billion)
      1. 4.3.1 Cardiovascular
      2. 4.3.2 Oncology
      3. 4.3.3 Diabetes
      4. 4.3.4 Neurology
      5. 4.3.5 Infectious Diseases
    4. 4.4 Pharmaceutical, BY Formulation (USD Billion)
      1. 4.4.1 Tablets
      2. 4.4.2 Injectables
      3. 4.4.3 Topicals
      4. 4.4.4 Liquids
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 CVS Health (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Walgreens Boots Alliance (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Roche (CH)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 McKesson (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Cigna (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Cardinal Health (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 AstraZeneca (GB)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Sanofi (FR)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 GSK (GB)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
      10. 5.2.10 Novartis (CH)
        1. 5.2.10.1 Financial Overview
        2. 5.2.10.2 Products Offered
        3. 5.2.10.3 Key Developments
        4. 5.2.10.4 SWOT Analysis
        5. 5.2.10.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
    3. 6.3 SOUTH KOREA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    4. 6.4 SOUTH KOREA MARKET ANALYSIS BY THERAPEUTIC AREA
    5. 6.5 SOUTH KOREA MARKET ANALYSIS BY FORMULATION
    6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
    9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    12. 6.12 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 (% SHARE)
    13. 6.13 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
    14. 6.14 PHARMACEUTICAL, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    15. 6.15 PHARMACEUTICAL, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
    16. 6.16 PHARMACEUTICAL, BY THERAPEUTIC AREA, 2024 (% SHARE)
    17. 6.17 PHARMACEUTICAL, BY THERAPEUTIC AREA, 2024 TO 2035 (USD Billion)
    18. 6.18 PHARMACEUTICAL, BY FORMULATION, 2024 (% SHARE)
    19. 6.19 PHARMACEUTICAL, BY FORMULATION, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      3. 7.2.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.2.4 BY FORMULATION, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1
Share::
WhatsApp icon
LinkedIn icon
X (Twitter) icon
ChatGPT icon
Perplexity icon
Request Free Sample

South Korea South Korea Pharmacy Market Segmentation

South Korea Pharmacy Market By Product Type (USD Billion, 2025-2035)

  • Prescription Drugs
  • Over-The-Counter Drugs
  • Vaccines
  • Homeopathic Medicine

South Korea Pharmacy Market By Distribution Channel (USD Billion, 2025-2035)

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
  • Specialty Pharmacy

South Korea Pharmacy Market By Therapeutic Area (USD Billion, 2025-2035)

  • Cardiovascular
  • Oncology
  • Diabetes
  • Neurology
  • Infectious Diseases

South Korea Pharmacy Market By Formulation (USD Billion, 2025-2035)

  • Tablets
  • Injectables
  • Topicals
  • Liquids
Share::
WhatsApp icon
LinkedIn icon
X (Twitter) icon
ChatGPT icon
Perplexity icon
Request Free Sample

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.